Keros Therapeutics, Inc.
KROS
$11.58
$0.110.96%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 69.09% | 84.33% | 26.03% | 25.90% | 18.67% |
| Total Receivables | 308.43% | 114.14% | 39.52% | 55.28% | 29.73% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.93% | -5.71% | 14.81% | 42.91% | -28.38% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 69.70% | 30.01% | 156.14% | 102.72% | 273.30% |
| Total Current Assets | 69.57% | 81.33% | 29.44% | 27.86% | 21.53% |
|
|
|||||
| Total Current Assets | 69.57% | 81.33% | 29.44% | 27.86% | 21.53% |
| Net Property, Plant & Equipment | 20.65% | 27.14% | -0.82% | 0.68% | 10.81% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.38% | 8.97% | 16.06% | 11.90% | -5.25% |
| Total Assets | 66.44% | 77.56% | 27.71% | 26.37% | 20.62% |
|
|
|||||
| Total Accounts Payable | -15.56% | 28.81% | 57.62% | 6.49% | 63.22% |
| Total Accrued Expenses | 18.55% | 85.03% | 14.14% | 13.01% | 43.74% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 96.82% | 203.93% | -- | -- | 120.88% |
| Total Finance Division Other Current Liabilities | -37.44% | -18.24% | 8.37% | 174.92% | -11.33% |
| Total Other Current Liabilities | -37.44% | -18.24% | 8.37% | 174.92% | -11.33% |
| Total Current Liabilities | 12.62% | 73.68% | 32.00% | 21.09% | 47.30% |
|
|
|||||
| Total Current Liabilities | 12.62% | 73.68% | 32.00% | 21.09% | 47.30% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 25.63% | 27.18% | -7.81% | -6.00% | 4.90% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 17.25% | 52.72% | 13.51% | 8.22% | 28.80% |
|
|
|||||
| Common Stock & APIC | 59.79% | 65.71% | 41.83% | 41.87% | 41.08% |
| Retained Earnings | -49.12% | -53.22% | -55.69% | -60.67% | -66.97% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 72.04% | 80.11% | 29.01% | 27.88% | 19.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 72.04% | 80.11% | 29.01% | 27.88% | 19.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 72.04% | 80.11% | 29.01% | 27.88% | 19.75% |
|
|
|||||
